SLC25A23 and colon adenocarcinoma: SLC25A23 had significantly low expression in colon cancer (P < 0.001) (Figure 8(d)), which was consistent with our bioinformatics prediction, while the alteration of SLC25A7 expression in COAD did not reach statistical significance (Figure 8(b)).